1492 Capital Management’s SOPHiA GENETICS SOPH Stock Holding History

1492 Capital Management’s Portfolio SOPH Stock Details SOPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.28M	Sell	222,194 -3,557	-2%	-$18K	0.38%	69
2026 Q1	$1.12M	Buy	225,751 +17,406	+8%	+$84.7K	0.43%	68
2025 Q4	$973K	Buy	+208,345	New	+$944K	0.37%	69

Other funds holding SOPH

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

AKRE Capital Management Middleburg, Virginia $5.12B AUM 19.08% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Principal Financial Group

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return

1492 Capital Management's SOPH Position: Q2 2026 in Review

1492 Capital Management reduced its SOPHiA GENETICS (SOPH) stake by 1.6% in Q2 2026, selling an estimated $18K and leaving 222,194 shares worth $1.28M. The position accounts for 0.38% of the portfolio, ranked #69.

1492 Capital Management first reported a position in SOPH in Q4 2025 and has held it in 3 quarters since. 72 funds tracked by Wall St. Rank hold SOPH as of Q2 2026.

1492 Capital Management held 222,194 shares of SOPHiA GENETICS worth $1.28M as of Q2 2026.
1492 Capital Management sold 3,557 SOPHiA GENETICS shares in Q2 2026, an estimated $18K.
SOPHiA GENETICS made up 0.38% of 1492 Capital Management's portfolio in Q2 2026, its #69 holding.
1492 Capital Management first reported a position in SOPHiA GENETICS in Q4 2025 and has held it in 3 quarters since.
72 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q2 2026.

Based on 1492 Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.